Keros received orphan drug designation from the US FDA for its investigational therapy KER-065 to treat Duchenne muscular ...

The FDA, which was originally going to make a decision by 19 August, has now pushed the target action dates back to Q4 2025.

In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Madrigal Pharmaceuticals’ Rezdiffra has been approved in Europe for the treatment of MASH with moderate to advanced liver ...